Severe Graves' Ophthalmopathy may be a risk factor for the development of postthyroidectomy hypocalcaemia

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 10, 2008, Pages 614-618

  Hassan, I ^a,c   Danila, R ^a,c   Maurer, E ^a,c   Osei Agymang, T ^a,c   Zielke, A ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Klinikum Offenbach   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cross sectional study; Endocrine ophthalmopathy; Graves' disease; Hypoparathyroidism; NOSPECS

Indexed keywords

CALCIUM; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; HYPOCALCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARATHYROID TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SURGICAL RISK; THYROIDECTOMY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; HYPOCALCEMIA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROIDECTOMY; THYROIDITIS, AUTOIMMUNE; YOUNG ADULT;

EID: 57049187755     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065333     Document Type: Article

References (33)

1. Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 2003; 133 (2): 180-185
2. Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH. Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? Thyroid 2005; 15 (6): 569-574
3. Chiang FY, Wang LF, Huang YF, Lee KW, Kuo WR. Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve. Surgery 2005; 137 (3): 342-347
4. Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau JL, Racadot A, Proye C. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg 1998; 22 (7): 718-724
5. Demeester-Mirkine N, Hooghe L, Geetruyden J Van, Maer- telaer V de. Hypocalcemia after thyroidectomy. Arch Surg 1992; 127: 854-858
6. MacHenry CR, Speroff T, Wentworth D, Murphy T. Risk factors for post-thyroidectomy hypocalcemia. Surgery 1994; 116: 641-648
7. Herranz-Gonzalez J, Garlian J, Martinez-Vidal J, Gavilan C. Complications following thyroid surgery. Arch Otolaryngol Head Neck Surg 1991; 117: 516-518
8. Shindo ML, Sinha UK, Rice DH. Safety of thyroidectomy in residency: a review of 186 consecutive cases. Laryngoscope 1995; 105: 1173-1175
9. Wingert DJ, Friesein SR, Illio Poulos JI et al. Post-thyroidectomy hypocalcemia: incidence and risks factors. Am J Surg 1986; 152: 606-610
10. Bahn RS, Heufelder AE. Mechanisms of disease: pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993; 329: 1468-1475
11. Yamada M, Li AW, Wall JR. Thyroid-associated ophthalmopathy: clinical features, pathogenesis and management. Crit Rev Clin Lab Sci 2000; 37: 523-549
12. Mizokami T, Salvi M, Wall JR. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon? J Endocrinol Invest 2004; 27: 221-229
13. El Kaissi Frauman A, Wall JR. Thyroid-associated ophthalmopathy - a practical guide to classification, natural history and management. Int Med J 2004; 34: 482-491
14. Hassan I, Koller M, Kluge C, Hoffmann S, Zielke A, Rothmund M. Supervised surgical trainees perform thyroid surgery for Graves' disease safely. Langenbecks Arch Surg 2006; 391 (6): 597-602
15. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association. J Clin Endocrinol Metab 1977; 44: 203-204
16. Stan MN, Garrity JA, Bradley EA, Woog JJ, Bahn MM, Brennan MD, Bryant SC, Achenbach SJ, Bahn RS. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. J Clin Endocrinol Metab 2006; 91 (12): 4817-4824
17. Delbridge L. Total thyroidectomy: the evolution of surgical technique. ANZ Journal of Surgery 2003; 73 (9): 761-768
18. Reber PM, Heath H. Hypocalcemic emergencies. Med Clin North Am 1995; 79: 93
19. Bellamy RJ, Kendall-Taylor P. Unrecognized hypocalcaemia diagnosed 36 years after thyroidectomy. J R Soc Med 1995; 88: 690
20. Ku CF, Lo CY, Chan WF, Kung AW, Lam KS. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease. ANZ J Surg 2005 Jul; 75 (7): 528-531
21. Dolapci M, Doganay M, Reis E, Kama NA. Truncal ligation of the inferior thyroid arteries does not affect the incidence of hypocalcaemia after thyroidectomy. Eur J Surg 2000; 166 (4): 286-288
22. Prim MP, Diego JI de, Hardisson D, Madero R, Gavilan J. Factors related to nerve injury and hypocalcemia in thyroid gland surgery. Otolaryngol Head Neck Surg 2001; 124 (1): 111-1114
23. Pantazi H, Papapetrou PD. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 2000; 85 (3): 1099-1106
24. Weetman P. The spectrum of autoimmunity in thyroid disease. Thyroid international 2005; 1: 3-13
25. Goswami R, Brown EM, Kochupillai N, Gupta N, Rani R, Kifor O, Chattopadhyay N. Prevalence of calcium sending receptor autoanti-bodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 2004; 150: 9-18
26. Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, Maclaren N. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97: 910-914
27. Peterson P, Krohn KJ. Mapping of B cell epitopes on steroid 17 alpha-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type 1. Clin Exp Immunol 1994; 98: 104-109
28. Cakir M, Karayalcin U. Graves' disease coexisting with probable autoimmune hypoparathyroidism. Exp Clin Endocrinol Diabetes 2003 Sep; 111 (6): 374-376
29. Gopinath B, Ma G, Wall JR. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis. Thyroid 2007 22; 17 (11): 1123-1129
30. Gopinath B, Adams CL, Musselman R, Tani J, Wall JR. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction. Ocul Immunol Inflamm 2007 Mar-Apr; 15(2): 81-88
31. Bednarczuk T, Gopinath B, Ploski R, Wall JR. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 2007; 67 (1): 3-19
32. Chen QY, Kukreja A, Maclaren NK. The autoimmune polyglandular syndromes. DeGroot LJ, Jameson JL, Eds.; Endocrinology. 4th ed. Philadelphia: WB Saunders Company 2001; 587-599
33. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 2002; 31: 295-320